APA (7th ed.) Citation

Crotti, C., Zucchi, F., Alfieri, C., Caporali, R., & Varenna, M. (2023). Long-term use of burosumab for the treatment of tumor-induced osteomalacia. Osteoporosis International, 34(1), 201. https://doi.org/10.1007/s00198-022-06516-6

Chicago Style (17th ed.) Citation

Crotti, C., F. Zucchi, C. Alfieri, R. Caporali, and M. Varenna. "Long-term Use of Burosumab for the Treatment of Tumor-induced Osteomalacia." Osteoporosis International 34, no. 1 (2023): 201. https://doi.org/10.1007/s00198-022-06516-6.

MLA (9th ed.) Citation

Crotti, C., et al. "Long-term Use of Burosumab for the Treatment of Tumor-induced Osteomalacia." Osteoporosis International, vol. 34, no. 1, 2023, p. 201, https://doi.org/10.1007/s00198-022-06516-6.